Abstract
We have analysed the genetic alteration of the entire coding region and all splice sites of caspase-8 and -10 genes in 99 gastric cancers by polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) and sequencing. We found LOH of the caspase-8 and -10 in nine (28%) of 32 and in four (15%) of 26 informative cases, respectively. Overall, three of 99 gastric cancers (3%) were found to have the caspase-10 mutations, which were identified in the coding regions of the death effector domain (codon 147) and the p17 large protease domain (codons 257 and 410), whereas no mutation was detected in caspase-8. In vitro expression studies, the M147T and Q257stop mutants severely impaired caspase-10-mediated apoptosis, whereas the V410I which was the same mutation detected in ALPS patient had a significant, albeit less severe, effect on apoptosis. The data presented here suggest that somatic alterations of the caspase-10 gene might contribute to the pathogenesis in a subset of gastric cancers through the loss of their apoptotic function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES . 1996 Proc. Natl. Acad. Sci. USA 93: 7464–7469
Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, STrober W, Lenardo MJ, Puck JM . 1995 Cell 81: 935–946
Grønbæk K, Straten PT, Ralfkiaer E, Ahrenkiel V, Andersen MK, Hansen NE, Zeuthen J, Hou-Jensen K, Guldberg P . 1998 Blood 92: 3018–3024
Grønbæk K, Dalby T, Seuthen J, Ralfkiaer E, Guldberg P . 2000 Blood 95: 2184–2185
Hopkins-Donaldson S, Bodmer J-L, Bourloud KB, Brognara CB, Tschopp J, Gross N . 2000 Cancer Res. 60: 4315–4319
Kohno T, Morishita K, Takano H, Shapiro DN, Yokota J . 1994 Oncogene 9: 103–108
Landowsky TH, Qu N, Buyuksal I, Painter JS, Dalton WS . 1997 Blood 90: 4266–4270
Lauren P . 1965 Acta Pathol. Microbiol. Scand. 64: 31–49
Lee JY, Dong SM, Kim SY, Yoo NJ, Lee SH, Park WS . 1998a Virchows Arch. 433: 305–309
Lee SH, Kim SY, Lee JY, Shin MS, Dong SM, Na EY, Park WS, Kim KM, Kim CS, Kim SH, Yoo NJ . 1998b Lab. Invest. 78: 453–459
Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, Park GS, Dong SM, Pi JH, Kim CS, Kim SH, Lee JY, Yoo NJ . 1999 Oncogene 18: 3754–3760
Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen P . 1997 J. Exp. Med. 186: 785–793
Nagata S . 1997 Cell 88: 355–365
Ng PW, Porter AG, Janicke RU . 1999 J. Biol. Chem. 274: 10301–10308
Nishizuka S, Tamura G, Terashima M, Satodate T . 1998 J. Pathol. 185: 38–43
Otsuka T, Kohno T, Mori M, Noguchi M, Hirohashi S, Yokota J . 1996 Genes Chromosomes Cancer 16: 113–119
Park WS, Oh RR, Kim YS, Park JY, Lee SH, Shin MS, Kim SY, Kim PJ, Lee HK, Yoo NJ, Lee JY . 2001 J. Pathol. 193: 162–168
Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Bostein D, Ashkenazi A . 1998 Nature 396: 699–703
Shin MS, Park WS, Kim SY, Kim HS, Kang SJ, Song KY, Park JY, Dong SM, Pi JH, Oh RR, Lee JY, Yoo NJ, Lee SH . 1999 Am. J. Pathol. 154: 1785–1791
Takita J, Yang HW, Chen YY, Hanada R, Yamamoto K, Teitz T, Kidd V, Hayashi Y . 2001 Oncogene 20: 4424–4432
Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lathi JM, Kidd VJ . 2000 Nature Med. 6: 529–535
Thompson CB . 1995 Science 267: 1456–1462
Vincenz C, Dixit VM . 1997 J. Biol. Chem. 272: 6578–6583
Wang J, Zheng L, Lobito A, Chan FK, Dale J, Sneller M, Yao X, Puck JM, Straus SE, Lenardo MJ . 1999 Cell 98: 47–58
Wyllie AH, Bellamy COC, Clarke AR, Corbet S, Curtis L, Harison DJ, Hooper ML, Webb S, Bird CC . 1999 Br. J. Cancer 80: 34–37
Acknowledgements
This work was supported by the KOSEF through the Cancer Metastasis Research Center (CMRC) at Yonsei University and the 21C Frontier Functional Human Genome Project (Number F-1-1-02) from Ministry of Science and Technology of Korea.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, W., Lee, J., Shin, M. et al. Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene 21, 2919–2925 (2002). https://doi.org/10.1038/sj.onc.1205394
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205394
Keywords
This article is cited by
-
A Review on Caspases: Key Regulators of Biological Activities and Apoptosis
Molecular Neurobiology (2023)
-
Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis
Applied Biochemistry and Biotechnology (2021)
-
Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis
Nature Communications (2019)
-
Differential roles of protease isoforms in the tumor microenvironment
Cancer and Metastasis Reviews (2019)
-
Genetic characterization of two gain-of-function alleles of the effector caspase DrICE in Drosophila
Cell Death & Differentiation (2016)